Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Intensive Care
43%
Maastricht
43%
Coronavirus Disease (COVID)
43%
Rotational Thromboelastometry (ROTEM)
34%
Sarcoidosis
26%
Uveitis
17%
Polymorphism
12%
Low Molecular Weight Heparin
11%
COVID-19
11%
Drug-induced
10%
Risk Factors
10%
Critically Ill COVID-19 Patients
9%
Fibrinogen
9%
Unfractionated Heparin
9%
Dutch
9%
Nephrolithiasis
8%
Risk Stratification
8%
Drug-induced Interstitial Lung Disease
8%
COVID-19 Disease
8%
Critical COVID-19
8%
Heparin Monitoring
8%
Drug-gene
8%
Patient Observation
8%
Comorbidity
8%
Dephosphorylated Uncarboxylated Matrix Gla Protein
8%
Matrix Gla Protein
8%
Vitamin K Epoxide Reductase
8%
Thrombin Generation
8%
Alternative Anticoagulants
8%
Quantra
8%
QPlus
8%
Goal-directed Transfusions
8%
Surgery Patients
8%
Clinical Pattern
8%
Prospective Observational Study
8%
Cardiothoracic Surgery
8%
Transfusion Protocol
8%
National Collaboration
8%
COVID-19 Pandemic
8%
Vitamin K Antagonists
8%
Patients at Risk
8%
Plasma Proteomics
8%
Proteomic Profile
8%
Unknown Cause
8%
Bleeding Disorders
8%
Meta-analysis
8%
Systematic Meta-analysis
8%
Pulmonary Thrombosis
8%
In Situ Thrombosis
8%
Non-survivors
7%
Drug Use
7%
Transfusion
6%
Plasma Profile
5%
Mass Spectrometry
5%
Plasma Protein Levels
5%
SARS-CoV-2 Infection
5%
International Normalized Ratio
5%
Intensive Care Unit
5%
Tissue Plasminogen Activator (t-PA)
5%
Clotting Time
5%
Intubation
5%
Survivors
5%
Hemostasis
5%
University Medical Centre
5%
Maastricht University
5%
INIS
patients
100%
risks
40%
diseases
35%
covid-19
35%
proteins
20%
comparative evaluations
20%
vitamin k
18%
levels
18%
units
17%
drugs
17%
exploration
17%
mortality
14%
plasma
12%
data
12%
heparin
12%
monitoring
11%
reviews
11%
genetics
11%
genes
10%
thrombosis
10%
biological markers
10%
surgery
9%
design
9%
anticoagulants
9%
lungs
9%
fibrinogen
8%
stratification
8%
matrices
8%
interstitials
8%
applications
8%
reductases
8%
thrombin
8%
epoxides
8%
transfusions
8%
appraisal
8%
phenotype
8%
emboli
8%
inflammation
8%
tissues
8%
control
6%
plasminogen
6%
molecular weight
5%
adjustments
5%
symptoms
5%
laboratories
5%
evaluation
5%
management
5%
Medicine and Dentistry
COVID-19
52%
Intensive Care
43%
Thromboelastometry
26%
Sarcoidosis
17%
Intensive Care Unit
15%
Pulmonary Embolism
13%
Diseases
12%
Observational Study
10%
Heparin
10%
Thrombosis
9%
Biological Marker
9%
Anticoagulant
8%
Risk Stratification
8%
Kidney Stone
8%
Retinol
8%
Thrombin
8%
Interstitial Lung Disease
8%
Vitamin K Epoxide Reductase
8%
Thorax Surgery
8%
Matrix Gla Protein
8%
Comorbidity
8%
Critical Appraisal
8%
Bleeding Disorder
8%
Meta-Analysis
8%
Systematic Review
8%
Uveitis
8%
Acute Respiratory Distress Syndrome
8%
Low Molecular Weight Heparin
8%
Fibrinogen
6%
Blood Stasis
5%
Intubation
5%
Tissue Plasminogen Activator
5%
Bleeding
5%